Dabigatran

Anti-HOXA3 homeobox A3, 100ul UN 1687 6.1 PG2

Anti-HOXA3 homeobox A3, 25ul UN 1687 6.1 PG2

Application Reactant for: Protein assembly directed by synthetic molecular recognition motifs Solid phase synthesis of gramicidin S cyclic analogs with antibiotic and hemolytic activities Synthesis of HCV protease inhibitor modified analogs Solid

Application Reactant for: Protein assembly directed by synthetic molecular recognition motifs Solid phase synthesis of gramicidin S cyclic analogs with antibiotic and hemolytic activities Synthesis of HCV protease inhibitor modified analogs Solid

Application Prediluted for use in Immunohistochemical staining procedures. For example: Blocking Reagent Primary Antibody or Negative Control Reagent Biotinylated Secondary Antibody Streptavidin-Enzyme Conjugate Chromogen Counterstain For best

Application Prediluted for use in Immunohistochemical staining procedures. For example: Blocking Reagent Primary Antibody or Negative Control Reagent Biotinylated Secondary Antibody Streptavidin-Enzyme Conjugate Chromogen Counterstain For best

Fmoc-Dap(Z)-OH

Cell Line Origin Human Caucasian promyelocytic leukaemia Cell Line Description HL60 15-12 is a variant of HL60 which is capable of differentiating towards either neutrophils or monocytes with treatment of appropriate agents. Culture Medium RPMI

Cell Line Origin Human Caucasian promyelocytic leukaemia Cell Line Description Variant of the promyelocytic cell line HL60 isolated after treating cells with &#945-particle radiation and then cloned in medium containing 1.25% DMSO.

Cell Line Origin Human Caucasian promyelocytic leukaemia Cell Line Description Variant of the promyelocytic cell line HL60 isolated after treating cells with &#945-particle radiation and then cloned in medium containing 1.25% DMSO.

Cell Line Origin Human cervix carcinoma Cell Line Description Originally derived from a human monocytic leukaemia. The cells support the growth of poliovirus I, adenovirus 3 and VSV (Indiana strain) This cell line was found to be indistinguishable

A cell permeable, highly potent, selective, and ATP-competitive inhibitor of receptor-interacting protein 2 (RIPK2, IC&#8325&#8320 = 5.3 nM).